Executive Vice President, President of Consumer Self Care Americas
Big things happened for Perrigo in 2021.
In July, the Dublin-based company completed the sale of its Generic Rx Pharmaceuticals business to Altaris Capital Partners for $1.55 billion, accomplishing Perrigo’s transformation from a drug maker to a global consumer self-care company — a strategy the company announced in 2019.
Perrigo in October then tapped Jim Dillard, its former executive vice president and chief scientific officer, to head up its Consumer Self-Care Americas (CSCA) division, previously led by Rich Sorota, who joined the company from Ranir after its acquisition by Perrigo in 2019.
Dillard reports to Murray Kessler, Perrigo’s president and CEO, and is based in Grand Rapids, which will be the new home of Perrigo’s North American headquarters, expected to be completed later this year.
Perrigo broke ground on the 125,000-square-foot building that’s part of the Michigan State University Grand Rapids Innovation Park in April 2021. It includes a 63,550-square-foot office space that will serve as the home base for Perrigo’s CSCA business on the building’s top three floors and will act as a catalyst for the creation of 170 jobs on Medical Mile.
MSU and Perrigo in January 2021 inked a formal partnership connecting the university’s clinical and research expertise with Perrigo’s product innovation, manufacturing scale and retail partnerships to “empower consumers to take control of their self-care needs.”
Dillard said he is eager to see Perrigo’s vision come to fruition.
“(I have) a deep passion for rapidly delivering new products and innovation that delight our customers and consumers,” he said.